Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limitedverified

BOT.AX

Price:

$0.457

Market Cap:

$830.66M

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that ...[Read more]

Industry

Biotechnology

IPO Date

1988-01-31

Stock Exchange

ASX

Ticker

BOT.AX

The Enterprise Value as of January 2025 (TTM) for Botanix Pharmaceuticals Limited (BOT.AX) is 751.35M

According to Botanix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 751.35M. This represents a change of 243.73% compared to the average of 218.59M of the last 4 quarters.

Botanix Pharmaceuticals Limited (BOT.AX) Historical Enterprise Value (quarterly & annually)

How has BOT.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Botanix Pharmaceuticals Limited over the last ten years is 87.67M. The current 751.35M Enterprise Value has changed 85.60% with respect to the historical average. Over the past ten years (40 quarters), BOT.AX's Enterprise Value was at its highest in in the June 2011 quarter at 1.77B. The Enterprise Value was at its lowest in in the September 2010 quarter at 0.

Quarterly (TTM)
Annual

Average

87.67M

Median

42.37M

Minimum

12.29M

Maximum

393.68M

Botanix Pharmaceuticals Limited (BOT.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Botanix Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 359.90%

Maximum Annual Enterprise Value = 393.68M

Minimum Annual Increase = -90.96%

Minimum Annual Enterprise Value = 12.29M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024393.68M181.68%
2023139.76M189.33%
202248.31M-14.56%
202156.54M359.90%
202012.29M-90.96%
2019136.04M273.45%
201836.43M181.29%
201712.95M-32.45%
201619.17M-10.89%
201521.51M-50.12%

Botanix Pharmaceuticals Limited (BOT.AX) Average Enterprise Value

How has BOT.AX Enterprise Value performed in the past?

The current Enterprise Value of Botanix Pharmaceuticals Limited (BOT.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

193.92M

5-year avg

130.12M

10-year avg

87.67M

Botanix Pharmaceuticals Limited (BOT.AX) Enterprise Value vs. Peers

How is BOT.AX’s Enterprise Value compared to its peers?

Botanix Pharmaceuticals Limited’s Enterprise Value is greater than MGC Pharmaceuticals Limited (21.58M), greater than Zelira Therapeutics Limited (12.51M), greater than Creso Pharma Limited (28.39M), greater than Cann Group Limited (91.19M), greater than Althea Group Holdings Limited (19.99M),

Build a custom stock screener for Botanix Pharmaceuticals Limited (BOT.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Botanix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Botanix Pharmaceuticals Limited (BOT.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Botanix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Botanix Pharmaceuticals Limited's Enterprise Value?

What is the highest Enterprise Value for Botanix Pharmaceuticals Limited (BOT.AX)?

What is the 3-year average Enterprise Value for Botanix Pharmaceuticals Limited (BOT.AX)?

What is the 5-year average Enterprise Value for Botanix Pharmaceuticals Limited (BOT.AX)?

How does the current Enterprise Value for Botanix Pharmaceuticals Limited (BOT.AX) compare to its historical average?